Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia

Clinical trial NCT01793935 · COMPLETED

Trial details

NCT number: NCT01793935
Sponsor: K.N. Roy Chengappa
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2013-04-01
Primary completion: 2016-07-07
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.